id stringlengths 8 8 | name stringlengths 5 37 | translator_id stringlengths 9 29 | drugbank_id stringlengths 7 12 ⌀ | synonyms listlengths 1 4 | aggregated_with listlengths 1 13 | drug_class stringlengths 4 79 ⌀ | therapeutic_area stringclasses 98 values | drug_function stringlengths 5 201 ⌀ | drug_target stringlengths 2 221 ⌀ | approved_usa stringclasses 3 values | is_antipsychotic bool 2 classes | is_sedative bool 2 classes | is_antimicrobial bool 2 classes | is_glucose_regulator bool 2 classes | is_chemotherapy bool 2 classes | is_steroid bool 2 classes | is_analgesic bool 2 classes | is_cardiovascular bool 2 classes | is_cell_therapy bool 2 classes | smiles stringlengths 4 852 ⌀ | atc_main stringclasses 348 values | atc_level_1 stringclasses 14 values | atc_level_2 stringclasses 79 values | atc_level_3 stringclasses 149 values | atc_level_4 stringclasses 275 values | atc_level_5 stringclasses 47 values | l1_label stringclasses 14 values | l2_label stringclasses 79 values | l3_label stringclasses 146 values | l4_label stringclasses 272 values | l5_label stringclasses 47 values | deleted bool 2 classes | deleted_reason stringclasses 6 values | new_id stringclasses 4 values | __index_level_0__ int64 0 1.81k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EC:01147 | Nitisinone | CHEBI:50378 | DB00348 | [
""
] | [
""
] | 4-Hydroxyphenylpyruvate Dioxygenase inhibitor | Metabolic | Anti-tyrosine accumulation | 4-Hydroxyphenylpyruvate Dioxygenase Inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | [O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O | A16AX | A | A16 | A16A | A16AX | null | alimentary tract and metabolism | other alimentary tract and metabolism products | other alimentary tract and metabolism products | various alimentary tract and metabolism products | null | false | null | null | 0 |
EC:00551 | Dutasteride | CHEBI:521033 | DB01126 | [
""
] | [
""
] | 5 Alpha-Reductase inhibitor | Endocrine; Genitourinary | Anti-androgen | 5 Alpha-Reductase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 1 |
EC:00682 | Finasteride | CHEBI:5062 | DB01216 | [
""
] | [
""
] | 5 Alpha-Reductase inhibitor | Genitourinary | Anti-androgen | 5 alpha-reductase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | [H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 2 |
EC:00156 | Balsalazide | PUBCHEM.COMPOUND:54585 | DB01014 | [
"Balsalazide sodium"
] | [
""
] | 5-Aminosalicylic Acid Derivative | Immune | Immunosuppressant | 5-Aminosalicylic Acid Derivative | APPROVED | false | false | false | false | false | false | false | false | false | OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O | S01BC | S | S01 | S01B | S01BC | null | sensory organs | ophthalmologicals | antiinflammatory agents | antiinflammatory agents, non-steroids | null | false | null | null | 3 |
EC:01013 | Mesalazine | CHEBI:6775 | DB00244 | [
"Mesalamine",
"5-aminosalicylic acid"
] | [
""
] | 5-Aminosalicylic Acid Derivative | Immune | Antiinflammatory | 5-Aminosalicylic Acid Derivative | APPROVED | false | false | false | false | false | false | false | false | false | NC1=CC(C(O)=O)=C(O)C=C1 | A07EC | A | A07 | A07E | A07EC | null | alimentary tract and metabolism | antidiarrheals, intestinal antiinflammatory/antiinfective agents | intestinal antiinflammatory agents | aminosalicylic acid and similar agents | null | false | null | null | 4 |
EC:01181 | Olsalazine | CHEBI:7770 | DB01250 | [
"Olsalazine sodium"
] | [
""
] | 5-Aminosalicylic Acid Derivative | Immune | Antiinflammatory | 5-Aminosalicylic Acid Derivative | APPROVED | false | false | false | false | false | false | false | false | false | OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(O)C(=C1)C(O)=O | A07EC | A | A07 | A07E | A07EC | null | alimentary tract and metabolism | antidiarrheals, intestinal antiinflammatory/antiinfective agents | intestinal antiinflammatory agents | aminosalicylic acid and similar agents | null | false | null | null | 5 |
EC:01539 | Sulfasalazine | CHEBI:9334 | DB00795 | [
""
] | [
""
] | 5-Aminosalicylic Acid Derivative | Immune | Antiinflammatory | 5-Aminosalicylic Acid Derivative | APPROVED | false | false | false | false | false | false | false | false | false | OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1 | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 6 |
EC:01777 | Zileuton | CHEBI:10112 | DB00744 | [
""
] | [
""
] | 5-Lipoxygenase Inhibitor | Respiratory | Inhibits leukotriene formation | 5-Lipoxygenase Inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1 | R03DC | R | R03 | R03D | R03DC | null | respiratory system | drugs for obstructive airway diseases | other systemic drugs for obstructive airway diseases | leukotriene receptor antagonists | null | false | null | null | 7 |
EC:00171 | Benazepril | CHEBI:3011 | DB00542 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | [H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 8 |
EC:00273 | Captopril | CHEBI:3380 | DB01197 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 9 |
EC:00341 | Cilazapril | CHEBI:3698 | DB01340 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | NOT_APPROVED | false | false | false | false | false | false | false | true | false | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 10 |
EC:00584 | Enalapril | CHEBI:4784 | DB00584 | [
"Enalapril maleate"
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 11 |
EC:00585 | Enalaprilat | CHEBI:4786 | DB09477 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | [H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 12 |
EC:00721 | Fosinopril | UNII:R43D2573WO | DB00492 | [
"Fosinopril sodium"
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 13 |
EC:00817 | Imidapril | CHEBI:135654 | DB11783 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | NOT_APPROVED | false | false | false | false | false | false | false | true | false | [H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(=O)OCC)C(=O)N1C(=O)N(C)C[C@@]1([H])C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 14 |
EC:00936 | Lisinopril | CHEBI:43755 | DB00722 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 15 |
EC:01075 | Moexipril | CHEBI:6960 | DB00691 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 16 |
EC:01266 | Perindopril | CHEBI:8024 | DB00790 | [
"Perindopril arginine"
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | [H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 17 |
EC:01371 | Quinapril | CHEBI:8713 | DB00881 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 18 |
EC:01381 | Ramipril | CHEBI:8774 | DB00178 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | [H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 19 |
EC:01666 | Trandolapril | CHEBI:9649 | DB00519 | [
""
] | [
""
] | ACE inhibitor | Cardiovascular | Antihypertensive | ACE inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | [H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 20 |
EC:00177 | Benzgalantamine | UNII:XOI2Q0ZF7G | DB19353 | [
""
] | [
""
] | Acetylcholinesterase Inhibitor | Central nervous system | Increases ACh | acetylcholinesterase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | [H][C@]12C[C@@H](OC(=O)C3=CC=CC=C3)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13 | N07AA | N | N07 | N07A | N07AA | null | nervous system | other nervous system drugs | parasympathomimetics | anticholinesterases | null | false | null | null | 21 |
EC:00526 | Donepezil | CHEBI:145499 | DB00843 | [
"Donepezil hydrochloride"
] | [
""
] | Acetylcholinesterase Inhibitor | Central nervous system | Antidementia | Acetylcholinesterase inhibitor (central) | APPROVED | false | false | false | false | false | false | false | false | false | COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1 | N07AA | N | N07 | N07A | N07AA | null | nervous system | other nervous system drugs | parasympathomimetics | anticholinesterases | null | false | null | null | 22 |
EC:00733 | Galantamine | CHEBI:42944 | DB00674 | [
""
] | [
""
] | Acetylcholinesterase Inhibitor | Central nervous system | Increases ACh | Acetylcholinesterase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | [H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3 | S01EB | S | S01 | S01E | S01EB | null | sensory organs | ophthalmologicals | antiglaucoma preparations and miotics | parasympathomimetics | null | false | null | null | 23 |
EC:01281 | Physostigmine | CHEBI:27953 | DB00981 | [
""
] | [
""
] | Acetylcholinesterase Inhibitor | Central nervous system | Increases ACh | Acetylcholinesterase Inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | [H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C | V03AB | V | V03 | V03A | V03AB | null | various | all other therapeutic products | all other therapeutic products | antidotes | null | false | null | null | 24 |
EC:01430 | Rivastigmine | CHEBI:8874 | DB00989 | [
""
] | [
""
] | Acetylcholinesterase Inhibitor | Central nervous system | Antiparkinson agent | Acetylcholinesterase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C | N05BC | N | N05 | N05B | N05BC | null | nervous system | psycholeptics | anxiolytics | carbamates | null | false | null | null | 25 |
EC:01123 | Neostigmine | CHEBI:7514 | DB01400 | [
""
] | [
""
] | Acetylcholinesterase Inhibitor | Peripheral nervous system | parasympathomimetic | Acetylcholinesterase Inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C | S01EB | S | S01 | S01E | S01EB | null | sensory organs | ophthalmologicals | antiglaucoma preparations and miotics | parasympathomimetics | null | false | null | null | 26 |
EC:01364 | Pyridostigmine | CHEBI:8665 | DB00545 | [
"Pyridostigmine bromide"
] | [
""
] | Acetylcholinesterase Inhibitor | Peripheral nervous system | parasympathomimetic | Acetylcholinesterase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CN(C)C(=O)OC1=C[N+](C)=CC=C1 | S01EB | S | S01 | S01E | S01EB | null | sensory organs | ophthalmologicals | antiglaucoma preparations and miotics | parasympathomimetics | null | false | null | null | 27 |
EC:00170 | Bempedoic acid | CHEBI:149601 | DB11936 | [
""
] | [
""
] | ACL inhibitor | Cardiovascular | Lipid-lowering | Adenosine triphosphate-citrate lyase (ACL) inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O | C10A | C | C10 | C10A | null | null | cardiovascular system | lipid modifying agents | lipid modifying agents, plain | null | null | false | null | null | 28 |
EC:00399 | Corticotropin | CHEBI:3892 | DB01285 | [
""
] | [
""
] | ACTH receptor agonist | Dermatology; Immune | Adrenocorticotropin Stimulating Hormone | Stimulates adrenal cortex to secrete adrenal steroids | APPROVED | false | false | false | false | false | false | false | false | false | null | S03BA | S | S03 | S03B | S03BA | null | sensory organs | ophthalmological and otological preparations | corticosteroids | corticosteroids | null | false | null | null | 29 |
EC:00967 | Luspatercept | UNII:AQK7UBA1LS | DB12281 | [
""
] | [
""
] | Activin Receptor Ligand Trap | Hematology | Hematopoietic Agent | Activin Receptor type IIB–Fc Ligand Trap | APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 30 |
EC:01516 | Sotatercept | UMLS:C2699571 | DB12118 | [
""
] | [
""
] | Activin Receptor Ligand Trap | Hematology | Activin signalling inhibitor | Activin A Receptor IIA Ligand | APPROVED | false | false | false | false | false | false | false | false | false | null | C02KX | C | C02 | C02K | C02KX | null | cardiovascular system | antihypertensives | other antihypertensives | antihypertensives for pulmonary arterial hypertension | null | false | null | null | 31 |
EC:00096 | Apadamtase alfa | UMLS:C4547518 | DB15164 | [
"Adamts13"
] | [
""
] | ADAMTS13 replacement | Hematology | Thrombolytic | Recombinant human ADAMTS13 | APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 32 |
EC:00568 | Elapegademase | UNII:9R3D3Y0UHS | DB14712 | [
""
] | [
""
] | Adenosine deaminase enzyme replacement | Immune | Purine metabolism enzyme replacement | Adenosine deaminase enzyme replacement | APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 33 |
EC:00268 | Capivasertib | CHEBI:229222 | DB12218 | [
""
] | [
""
] | AKT inhibitor | Targeted cancer therapy | Small molecule inhibitor | AKT inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1 | L01E | L | L01 | L01E | null | null | antineoplastic and immunomodulating agents | antineoplastic agents | protein kinase inhibitors | null | null | false | null | null | 34 |
EC:00751 | Givosiran | UNII:ROV204583W | DB15066 | [
""
] | [
""
] | ALAS1-directed siRNA | Metabolic | Causes degradation of aminolevulinate synthase 1 (ALAS1) messenger RNA | ALAS1-directed siRNA | APPROVED | false | false | false | false | false | false | false | false | false | C[C@@H]1C[C@@H](O)CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)COCCC(=O)NCCCNC(=O)CCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O | V06DC | V | V06 | V06D | V06DC | null | various | general nutrients | other nutrients | carbohydrates | null | false | null | null | 35 |
EC:00008 | Acamprosate | CHEBI:51041 | DB00659 | [
"Acamprosate calcium"
] | [
""
] | Alcohol abstinence tool | Central nervous system | Reduce alcohol cravings | GABA agonist and partial NMDA antagonist | APPROVED | false | false | false | false | false | false | false | false | false | CC(=O)NCCCS(O)(=O)=O | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 36 |
EC:00714 | Fomepizole | CHEBI:5141 | DB01213 | [
""
] | [
""
] | Alcohol dehydrogenase inhibitor | Antidote | Methanol or ethylene glycol antidote | Alcohol dehydrogenase 2 inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CC1=CNN=C1 | V03AB | V | V03 | V03A | V03AB | null | various | all other therapeutic products | all other therapeutic products | antidotes | null | false | null | null | 37 |
EC:00516 | Disulfiram | CHEBI:4659 | DB00822 | [
""
] | [
""
] | Aldehyde dehydrogenase inhibitor | Metabolic; Central nervous system | Disulfuram reaction | Aldehyde dehydrogenase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CCN(CC)C(=S)SSC(=S)N(CC)CC | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 38 |
EC:00040 | Alectinib | CHEBI:90936 | DB11363 | [
""
] | [
""
] | ALK inhibitor | Targeted cancer therapy | Small molecule inhibitor | ALK inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O | L01ED | L | L01 | L01E | L01ED | null | antineoplastic and immunomodulating agents | antineoplastic agents | protein kinase inhibitors | anaplastic lymphoma kinase (alk) inhibitors | null | false | null | null | 39 |
EC:00227 | Brigatinib | CHEBI:232810 | DB12267 | [
""
] | [
""
] | ALK inhibitor | Targeted cancer therapy | Small molecule inhibitor | ALK inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1 | L01ED | L | L01 | L01E | L01ED | null | antineoplastic and immunomodulating agents | antineoplastic agents | protein kinase inhibitors | anaplastic lymphoma kinase (alk) inhibitors | null | false | null | null | 40 |
EC:00315 | Ceritinib | CHEBI:78432 | DB09063 | [
""
] | [
""
] | ALK inhibitor | Targeted cancer therapy | Small molecule inhibitor | ALK inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1 | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 41 |
EC:00592 | Ensartinib | UNII:SMA5ZS5B22 | DB14860 | [
""
] | [
""
] | ALK inhibitor | Targeted cancer therapy | Small molecule inhibitor | ALK inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | C[C@@H](OC1=CC(=NN=C1N)C(=O)NC1=CC=C(C=C1)C(=O)N1C[C@H](C)N[C@H](C)C1)C1=C(Cl)C=CC(F)=C1Cl | L01E | L | L01 | L01E | null | null | antineoplastic and immunomodulating agents | antineoplastic agents | protein kinase inhibitors | null | null | false | null | null | 42 |
EC:00952 | Lorlatinib | CHEBI:143117 | DB12130 | [
""
] | [
""
] | ALK inhibitor | Targeted cancer therapy | Small molecule inhibitor | ALK inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2 | N01BB | N | N01 | N01B | N01BB | null | nervous system | anesthetics | anesthetics, local | amides | null | false | null | null | 43 |
EC:00117 | Asfotase alfa | UNII:Z633861EIM | DB09105 | [
"Human recombinant alkaline phosphatase"
] | [
""
] | Alkaline phosphatase replacement | Musculoskeletal | Bone mineralisation | human recombinant tissue-nonspecific alkaline phosphatase | APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 44 |
EC:01698 | Tromethamine | CHEBI:9754 | DB03754 | [
"Tham"
] | [
""
] | Alkalizing agent | Metabolic | Alkalizing agent | Proton acceptor | APPROVED | false | false | false | false | false | false | false | false | false | NC(CO)(CO)CO | B05BB | B | B05 | B05B | B05BB | null | blood and blood forming organs | blood substitutes and perfusion solutions | i.v. solutions | solutions affecting the electrolyte balance | null | false | null | null | 45 |
EC:00246 | Busulfan | CHEBI:28901 | DB01008 | [
""
] | [
""
] | Alkyl sulfonate | Traditional cancer therapy | Alkylating agent | DNA | APPROVED | false | false | false | false | true | false | false | false | false | CS(=O)(=O)OCCCCOS(C)(=O)=O | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 46 |
EC:01675 | Treosulfan | CHEBI:82557 | DB11678 | [
""
] | [
""
] | Alkyl sulfonate | Traditional cancer therapy | Alkylating agent | DNA | APPROVED | false | false | false | false | true | false | false | false | false | CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 47 |
EC:00966 | Lurbinectedin | UNII:2CN60TN6ZS | DB12674 | [
""
] | [
""
] | Alkylating agent | Traditional cancer therapy | Alkylating agent | DNA minor groove binder | APPROVED | false | false | false | false | true | false | false | false | false | [H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31 | L01A | L | L01 | L01A | null | null | antineoplastic and immunomodulating agents | antineoplastic agents | alkylating agents | null | null | false | null | null | 48 |
EC:01662 | Trabectedin | CHEBI:84050 | DB05109 | [
""
] | [
""
] | Alkylating agent | Traditional cancer therapy | Alkylating agent | DNA minor groove binder | APPROVED | false | false | false | false | true | false | false | false | false | [H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4C=C(OC)C(O)=C5)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@H]2N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31 | L01A | L | L01 | L01A | null | null | antineoplastic and immunomodulating agents | antineoplastic agents | alkylating agents | null | null | false | null | null | 49 |
EC:01345 | Procarbazine | CHEBI:71417 | DB01168 | [
""
] | [
""
] | Alkylating agent | Traditional cancer therapy | Alkylating agent | Mech not known | APPROVED | false | false | false | false | true | false | false | false | false | CNNCC1=CC=C(C=C1)C(=O)NC(C)C | N01BB | N | N01 | N01B | N01BB | null | nervous system | anesthetics | anesthetics, local | amides | null | false | null | null | 50 |
EC:00247 | Butenafine | CHEBI:3238 | DB01091 | [
""
] | [
""
] | Allylamine antifungal | Antimicrobial; Dermatology | Antifungal | Topical antifungal | APPROVED | false | false | true | false | false | false | false | false | false | CN(CC1=CC=C(C=C1)C(C)(C)C)CC1=CC=CC2=CC=CC=C12 | S03AA | S | S03 | S03A | S03AA | null | sensory organs | ophthalmological and otological preparations | antiinfectives | antiinfectives | null | false | null | null | 51 |
EC:01099 | Naftifine | CHEBI:7451 | DB00735 | [
""
] | [
""
] | Allylamine antifungal | Antimicrobial; Dermatology; Ophthalmic | Antifungal | Broad spectrum allylamine | APPROVED | false | false | true | false | false | false | false | false | false | CN(CC=CC1=CC=CC=C1)CC1=CC=CC2=CC=CC=C12 | S03AA | S | S03 | S03A | S03AA | null | sensory organs | ophthalmological and otological preparations | antiinfectives | antiinfectives | null | false | null | null | 52 |
EC:00044 | Alfuzosin | CHEBI:51141 | DB00346 | [
"Alfuzosin hydrochloride"
] | [
""
] | Alpha blocker | Urological | Smooth muscle relaxer in bladder and prostate | Alpha-1 blockers | APPROVED | false | false | false | false | false | false | false | false | false | COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1 | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 53 |
EC:00535 | Doxazosin | CHEBI:4708 | DB00590 | [
""
] | [
""
] | Alpha blocker | Cardiovascular | Antihypertensive | Alpha1-adrenergic antagonist | APPROVED | false | false | false | false | false | false | false | true | false | COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1 | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 54 |
EC:01275 | Phenoxybenzamine | CHEBI:8077 | DB00925 | [
"Phenoxybenzamine hydrochloride"
] | [
""
] | Alpha blocker | Cardiovascular | Antihypertensive | Alpha1 and Alpha2 Blocker | APPROVED | false | false | false | false | false | false | false | true | false | CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1 | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 55 |
EC:01278 | Phentolamine | CHEBI:8081 | DB00692 | [
""
] | [
""
] | Alpha blocker | Cardiovascular; Ophthalmic | Antihypertensive | Alpha1 and Alpha2 Blocker | APPROVED | false | false | false | false | false | false | false | true | false | CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1 | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 56 |
EC:01333 | Prazosin | CHEBI:8364 | DB00457 | [
""
] | [
""
] | Alpha blocker | Cardiovascular | Antihypertensive | Alpha1 Blocker | APPROVED | false | false | false | false | false | false | false | true | false | COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1 | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 57 |
EC:01562 | Tamsulosin | CHEBI:9398 | DB00706 | [
"Tamsulosin hydrochloride"
] | [
""
] | Alpha blocker | Urological | Smooth muscle relaxer in bladder and prostate | Alpha-1A blocker | APPROVED | false | false | false | false | false | false | false | false | false | CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 58 |
EC:01596 | Terazosin | CHEBI:9445 | DB01162 | [
""
] | [
""
] | Alpha blocker | Cardiovascular; Urological | Antihypertensive | Alpha-1 blockers | APPROVED | false | false | false | false | false | false | false | true | false | COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1 | G04CA | G | G04 | G04C | G04CA | null | genito urinary system and sex hormones | urologicals | drugs used in benign prostatic hypertrophy | alpha-adrenoreceptor antagonists | null | false | null | null | 59 |
EC:01730 | Velmanase alfa | CHEBI:29105 | DB12374 | [
"Alpha mannosidase"
] | [
""
] | Alpha mannosidase replacement | Metabolic | Lysosomal enzyme replacement | exogenouse source of alpha mannosidase | APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 60 |
EC:00054 | Alpha-1-proteinase inhibitor | DRUGBANK:DB00058 | DB00058 | [
"Human alpha1-proteinase inhibitor"
] | [
""
] | Alpha-1 proteinase inhibitor | Respiratory | Enzyme replacement therapy | Alpha-1 proteinase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | null | J05AE | J | J05 | J05A | J05AE | null | antiinfectives for systemic use | antivirals for systemic use | direct acting antivirals | protease inhibitors | null | false | null | null | 61 |
EC:00100 | Apraclonidine | CHEBI:2788 | DB00964 | [
""
] | [
""
] | Alpha-adrenergic agonist | Ophthalmic | Reduce IOP | decrease aqueous humor production | Alpha-2 agonist | APPROVED | false | false | false | false | false | false | false | false | false | NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1 | S01EA | S | S01 | S01E | S01EA | null | sensory organs | ophthalmologicals | antiglaucoma preparations and miotics | sympathomimetics in glaucoma therapy | null | false | null | null | 62 |
EC:00228 | Brimonidine | CHEBI:3175 | DB00484 | [
"Brimonidine tartrate"
] | [
""
] | Alpha-adrenergic agonist | Ophthalmic | Antiglaucoma | miotic | Alpha-2 agonist | APPROVED | false | false | false | false | false | false | false | false | false | BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12 | S01GA | S | S01 | S01G | S01GA | null | sensory organs | ophthalmologicals | decongestants and antiallergics | sympathomimetics used as decongestants | null | false | null | null | 63 |
EC:01014 | Metaraminol | CHEBI:6794 | DB00610 | [
"Hydroxynorephedrine"
] | [
""
] | Alpha-adrenergic agonist | Cardiovascular | Vasoconstrictor | alpha-1 adrenergic receptor agonist | NOT_APPROVED | false | false | false | false | false | false | false | true | false | C[C@H](N)[C@H](O)C1=CC(O)=CC=C1 | R01BA | R | R01 | R01B | R01BA | null | respiratory system | nasal preparations | nasal decongestants for systemic use | sympathomimetics | null | false | null | null | 64 |
EC:01049 | Midodrine | CHEBI:6933 | DB00211 | [
"Midodrine hydrochloride"
] | [
""
] | Alpha-adrenergic agonist | Cardiovascular | Vasoconstriction and venoconstriction | increases arteriolar and venous tone | Alpha-1 agonist | APPROVED | false | false | false | false | false | false | false | true | false | COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1 | R01BA | R | R01 | R01B | R01BA | null | respiratory system | nasal preparations | nasal decongestants for systemic use | sympathomimetics | null | false | null | null | 65 |
EC:01106 | Naphazoline | CHEBI:93363 | DB06711 | [
""
] | [
""
] | Alpha-adrenergic agonist | Ophthalmic | Vasoconstrictor | Alpha1 Agonist | APPROVED | false | false | false | false | false | false | false | false | false | C(C1=NCCN1)C1=CC=CC2=CC=CC=C12 | S01GA | S | S01 | S01G | S01GA | null | sensory organs | ophthalmologicals | decongestants and antiallergics | sympathomimetics used as decongestants | null | false | null | null | 66 |
EC:01211 | Oxymetazoline | CHEBI:7862 | DB00935 | [
""
] | [
""
] | Alpha-adrenergic agonist | Cardiovascular | Vasoconstrictor | Adrenergic Agonist | APPROVED | false | false | false | false | false | false | false | true | false | CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C | S01GA | S | S01 | S01G | S01GA | null | sensory organs | ophthalmologicals | decongestants and antiallergics | sympathomimetics used as decongestants | null | false | null | null | 67 |
EC:01279 | Phenylephrine | CHEBI:8093 | DB00388 | [
"Phenylephrine hydrochloride"
] | [
""
] | Alpha-adrenergic agonist | Cardiovascular | Vasoconstrictor | Alpha-Adrenergic Agonist | APPROVED | false | false | false | false | false | false | false | true | false | CNC[C@H](O)C1=CC(O)=CC=C1 | S01FB | S | S01 | S01F | S01FB | null | sensory organs | ophthalmologicals | mydriatics and cycloplegics | sympathomimetics excl. antiglaucoma preparations | null | false | null | null | 68 |
EC:01357 | Propylhexedrine | CHEBI:134783 | DB06714 | [
""
] | [
""
] | Alpha-adrenergic agonist | Respiratory | Nasal decongestant | Adrenergic Agonist | APPROVED | false | false | false | false | false | false | false | false | false | CNC(C)CC1CCCCC1 | null | null | null | null | null | null | null | null | null | null | null | false | null | null | 69 |
EC:01767 | Xylometazoline | CHEBI:10082 | DB06694 | [
"Xylometazoline hydrochloride"
] | [
""
] | Alpha-adrenergic agonist | Respiratory | Decongestant | Alpha-Adrenergic Agonist | NOT_APPROVED | false | false | false | false | false | false | false | false | false | CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C | S01GA | S | S01 | S01G | S01GA | null | sensory organs | ophthalmologicals | decongestants and antiallergics | sympathomimetics used as decongestants | null | false | null | null | 70 |
EC:01608 | Tetryzoline | CHEBI:28674 | DB06764 | [
"Tetrahydrozoline"
] | [
""
] | Alpha-adrenergic agonist | Ophthalmic | Ocular decongestant | Vasoconstricter | Alpha adrenergic receptor agonist (conjunctival aterioles) | APPROVED | false | false | false | false | false | false | false | false | false | C1CN=C(N1)C1CCCC2=CC=CC=C12 | R01AA | R | R01 | R01A | R01AA | null | respiratory system | nasal preparations | decongestants and other nasal preparations for topical use | sympathomimetics, plain | null | false | null | null | 71 |
EC:00033 | Agalsidase alfa | UNII:2HLC17MX9G | DB15874 | [
"Recombinant human alpha-galactosidase a",
"Alpha galactosidase",
"Agalsidase beta"
] | [
""
] | Alpha-galactosidase replacement | Metabolic | Lysosomal enzyme replacement | Alpha-galactosidase replacement | NOT_APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 72 |
EC:01053 | Migalastat | CHEBI:135923 | DB05018 | [
""
] | [
""
] | Alpha-galactosidase replacement | Metabolic | Enzyme stabilizer | alpha-galactosidase A stabilizer | APPROVED | false | false | false | false | false | false | false | false | false | OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O | V06DC | V | V06 | V06D | V06DC | null | various | general nutrients | other nutrients | carbohydrates | null | false | null | null | 73 |
EC:01247 | Pegunigalsidase alfa | UNII:8M7V7Q6537 | DB14992 | [
""
] | [
""
] | Alpha-galactosidase replacement | Metabolic | Lysosomal enzyme replacement | Recombinant alpha-galactosidase-A | APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 74 |
EC:00884 | Laronidase | UNII:WP58SVM6R4 | DB00090 | [
""
] | [
""
] | Alpha-L-iduronidase replacement | Metabolic | Lysosomal enzyme replacement | alpha-L-iduronidase replacement | APPROVED | false | false | false | false | false | false | false | false | false | null | M09AB | M | M09 | M09A | M09AB | null | musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | other drugs for disorders of the musculo-skeletal system | enzymes | null | false | null | null | 75 |
EC:00060 | Amantadine | CHEBI:2618 | DB00915 | [
"Amantadine hydrochloride"
] | [
""
] | Amantadine | Central nervous system | Antiparkinson | NMDA receptor agonist | APPROVED | false | false | false | false | false | false | false | false | false | NC12CC3CC(CC(C3)C1)C2 | N04BB | N | N04 | N04B | N04BB | null | nervous system | anti-parkinson drugs | dopaminergic agents | adamantane derivatives | null | false | null | null | 76 |
EC:00113 | Articaine | CHEBI:91834 | DB09009 | [
""
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Local anesthetic | Voltage-gated sodium channel blocker | APPROVED | false | false | false | false | false | false | false | false | false | CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC | D11AC08 | D | D11 | D11A | D11AC | D11AC08 | dermatologicals | other dermatological preparations | other dermatological preparations | medicated shampoos | sulfur compounds | false | null | null | 77 |
EC:00240 | Bupivacaine | CHEBI:3215 | DB00297 | [
"Bupivacaine hydrochloride"
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Local anesthetic | Voltage-gated sodium channel blocker | APPROVED | false | false | false | false | false | false | false | false | false | CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C | N02BE | N | N02 | N02B | N02BE | null | nervous system | analgesics | other analgesics and antipyretics | anilides | null | false | null | null | 78 |
EC:00490 | Dibucaine | UNII:J31043J63M | DB00527 | [
"Cinchocaine"
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Local anesthetic | Voltage-gated sodium channel blocker | APPROVED | false | false | false | false | false | false | false | false | false | CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC | S02DA | S | S02 | S02D | S02DA | null | sensory organs | otologicals | other otologicals | analgesics and anesthetics | null | false | null | null | 79 |
EC:00911 | Levobupivacaine | CHEBI:6149 | DB01002 | [
""
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Local anesthetic | Voltage-gated sodium channel blocker | NOT_APPROVED | false | false | false | false | false | false | false | false | false | CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C | N02BE | N | N02 | N02B | N02BE | null | nervous system | analgesics | other analgesics and antipyretics | anilides | null | false | null | null | 80 |
EC:00923 | Lidocaine | CHEBI:6456 | DB00281 | [
"Lidocaine hydrochloride"
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Local anesthetic | Voltage-gated sodium channel blocker | APPROVED | false | false | false | false | false | false | false | false | false | CCN(CC)CC(=O)NC1=C(C)C=CC=C1C | S02DA | S | S02 | S02D | S02DA | null | sensory organs | otologicals | other otologicals | analgesics and anesthetics | null | false | null | null | 81 |
EC:01008 | Mepivacaine | CHEBI:6759 | DB00961 | [
"Mepivacaine hydrochloride"
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Analgesic | Voltage-gated sodium channel blocker | APPROVED | false | false | false | false | false | false | true | false | false | CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C | N01BB | N | N01 | N01B | N01BB | null | nervous system | anesthetics | anesthetics, local | amides | null | false | null | null | 82 |
EC:01340 | Prilocaine | CHEBI:8404 | DB00750 | [
"Prilocaine hydrochloride"
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Local anesthetic | Voltage-gated sodium channel blocker | APPROVED | false | false | false | false | false | false | false | false | false | CCCNC(C)C(=O)NC1=CC=CC=C1C | N02BE | N | N02 | N02B | N02BE | null | nervous system | analgesics | other analgesics and antipyretics | anilides | null | false | null | null | 83 |
EC:01439 | Ropivacaine | CHEBI:8890 | DB00296 | [
"Ropivacaine hydrochloride"
] | [
""
] | Amide local anesthetic | Peripheral nervous system | Local anesthetic | Voltage-gated sodium channel blocker | APPROVED | false | false | false | false | false | false | false | false | false | CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C | N02BE | N | N02 | N02B | N02BE | null | nervous system | analgesics | other analgesics and antipyretics | anilides | null | false | null | null | 84 |
EC:01526 | Streptomycin | CHEBI:17076 | DB01082 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Aminoglycoside antibiotic | APPROVED | false | false | true | false | false | false | false | false | false | CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O | S03AA | S | S03 | S03A | S03AA | null | sensory organs | ophthalmological and otological preparations | antiinfectives | antiinfectives | null | false | null | null | 85 |
EC:00065 | Amikacin | CHEBI:2637 | DB00479 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Aminoglycoside | APPROVED | false | false | true | false | false | false | false | false | false | NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O | S01AA | S | S01 | S01A | S01AA | null | sensory organs | ophthalmologicals | antiinfectives | antibiotics | null | false | null | null | 86 |
EC:00271 | Capreomycin | CHEBI:3371 | DB00314 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Antitubercular Agent | NOT_APPROVED | false | false | true | false | false | false | false | false | false | [H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O | S01AA | S | S01 | S01A | S01AA | null | sensory organs | ophthalmologicals | antiinfectives | antibiotics | null | false | null | null | 87 |
EC:00724 | Framycetin | CHEBI:7507 | DB00452 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial; Ophthalmic | Antibiotic | aminoglycoside derivative | NOT_APPROVED | false | false | true | false | false | false | false | false | false | NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O | V06DC | V | V06 | V06D | V06DC | null | various | general nutrients | other nutrients | carbohydrates | null | false | null | null | 88 |
EC:00745 | Gentamicin | PUBCHEM.COMPOUND:3467 | DB00798 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Aminoglycoside | APPROVED | false | false | true | false | false | false | false | false | false | [H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC | S03AA06 | S | S03 | S03A | S03AA | S03AA06 | sensory organs | ophthalmological and otological preparations | antiinfectives | antiinfectives | gentamicin | false | null | null | 89 |
EC:01122 | Neomycin | RXCUI:379383 | DB00994 | [
"Neomycin sulfate"
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Aminoglycoside antibiotic | APPROVED | false | false | true | false | false | false | false | false | false | null | V06DC | V | V06 | V06D | V06DC | null | various | general nutrients | other nutrients | carbohydrates | null | false | null | null | 90 |
EC:01238 | Paromomycin | CHEBI:7934 | DB01421 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antiparasitic | aminoglycoside | APPROVED | false | false | true | false | false | false | false | false | false | NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O | V06DC | V | V06 | V06D | V06DC | null | various | general nutrients | other nutrients | carbohydrates | null | false | null | null | 91 |
EC:01303 | Plazomicin | UNII:LYO9XZ250J | DB12615 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Aminoglycoside | APPROVED | false | false | true | false | false | false | false | false | false | CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O | S03AA06 | S | S03 | S03A | S03AA | S03AA06 | sensory organs | ophthalmological and otological preparations | antiinfectives | antiinfectives | gentamicin | false | null | null | 92 |
EC:01645 | Tobramycin | CHEBI:28864 | DB00684 | [
""
] | [
""
] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Aminoglycoside antibiotic | APPROVED | false | false | true | false | false | false | false | false | false | NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O | V06DC | V | V06 | V06D | V06DC | null | various | general nutrients | other nutrients | carbohydrates | null | false | null | null | 93 |
EC:01264 | Perampanel | CHEBI:71013 | DB08883 | [
""
] | [
""
] | AMPA receptor antagonist | Central nervous system | Antiepileptic | AMPA Glutamate Receptor Antagonist | APPROVED | false | false | false | false | false | false | false | false | false | O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1 | N03A | N | N03 | N03A | null | null | nervous system | antiepileptics | antiepileptics | null | null | false | null | null | 94 |
EC:00082 | Amphetamine | CHEBI:132233 | DB00182 | [
""
] | [
""
] | Amphetamine and derivatives | Central nervous system | CNS Stimulant | centrally acting sympathomimetics | APPROVED | false | false | false | false | false | false | false | false | false | CC(N)CC1=CC=CC=C1 | N06BA | N | N06 | N06B | N06BA | null | nervous system | psychoanaleptics | psychostimulants, agents used for adhd and nootropics | centrally acting sympathomimetics | null | false | null | null | 95 |
EC:00182 | Benzphetamine | CHEBI:3044 | DB00865 | [
""
] | [
""
] | Amphetamine and derivatives | Central nervous system | CNS Stimulant | Amphetamine deriative | APPROVED | false | false | false | false | false | false | false | false | false | C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1 | R01BA | R | R01 | R01B | R01BA | null | respiratory system | nasal preparations | nasal decongestants for systemic use | sympathomimetics | null | false | null | null | 96 |
EC:00485 | Dextroamphetamine | UNII:S76B51L5AM | DB01576 | [
"Dexamfetamine sulfate",
"Dexamfetamine"
] | [
""
] | Amphetamine and derivatives | Central nervous system | CNS stimulant | Amphetamine deriative | APPROVED | false | false | false | false | false | false | false | false | false | C[C@H](N)CC1=CC=CC=C1 | N06BA | N | N06 | N06B | N06BA | null | nervous system | psychoanaleptics | psychostimulants, agents used for adhd and nootropics | centrally acting sympathomimetics | null | false | null | null | 97 |
EC:00497 | Diethylpropion | CHEBI:4530 | DB00937 | [
"Amfepramone"
] | [
""
] | Amphetamine and derivatives | Central nervous system | CNS Stimulant | Anorexient | Amphetamine deriative | APPROVED | false | false | false | false | false | false | false | false | false | CCN(CC)C(C)C(=O)C1=CC=CC=C1 | R01BA | R | R01 | R01B | R01BA | null | respiratory system | nasal preparations | nasal decongestants for systemic use | sympathomimetics | null | false | null | null | 98 |
EC:00935 | Lisdexamfetamine | CHEBI:135925 | DB01255 | [
"Lisdexamfetamine mesilate"
] | [
""
] | Amphetamine and derivatives | Central nervous system | CNS Stimulant | Amphetamine deriative | APPROVED | false | false | false | false | false | false | false | false | false | C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN | N06BA | N | N06 | N06B | N06BA | null | nervous system | psychoanaleptics | psychostimulants, agents used for adhd and nootropics | centrally acting sympathomimetics | null | false | null | null | 99 |
End of preview. Expand
in Data Studio
Dataset Card for Every Cure Drug List
Dataset Summary
The Every Cure Drug List is a manually curated list of drug entities used by the MATRIX project for drug repurposing predictions. For reference, the list contains ~1,800 drugs with metadata including approval status, drug class flags, therapeutic annotations, and ATC classifications.
For more information see here.
Source Data
- Downloads last month
- 7